← TrendWatcher
arXiv cs.AI
6/10

Leverage Health

A chronic-condition companion that ranks every incoming recommendation (from doctors, AI apps, wearables, social media) by expected impact on your personal numbers and explicitly tells you which low-value habits to drop.

Target user

Adults managing diabetes, hypertension, or obesity who are overwhelmed by conflicting lifestyle advice from doctors, apps, social media, and wearables

Features
  • Insight Inbox that ranks incoming recommendations by expected change in your specific A1C, blood pressure, or weight
  • Drop-this alerts for low-impact habits so you stop tracking noise and reclaim attention
  • Weekly forgetting summary that retires metrics and rituals that aren't moving your outcomes
  • Care-team brief you can share with your clinician summarizing only the changes that actually mattered
Why now

The Calculus of Discernment paper validates value-aware forgetting and cuts decision regret 24-32% in obesity treatment, and chronic-condition patients face exactly this information overload from doctors, AI, wearables, and social media with no discernment layer.

Signals · overall 6/10
Demand
7/10

Global disease management apps market valued at ~$11B in 2024 growing at ~12% CAGR; chronic-condition tracking apps (diabetes, hypertension) are an established, growing category with explicit consumer guides published yearly.Disease Management Apps Market Size & Share Report, 2025-203315 Best Diabetes Apps [2024 Guide] | Health Reporter

Whitespace
6/10

Incumbents (Omada, Livongo, Virta, One Drop, MyFitnessPal) focus on tracking, coaching, or CGM-driven coaching; none position as a meta-discernment layer that ranks incoming recommendations across doctors/wearables/social and prescribes habit DROPS — closest analog is general-purpose habit trackers, not condition-specific ranking.Comparison of Omada Health, Livongo, and Virta Health Diabetes ProgramsThe Diabetes Solution Landscape: Compare Omada, Livongo, Teladoc, and Virta

Monetization
5/10

Pricing reality skews B2B2C: Virta self-pay and Omada pricing are plan/employer-mediated; Livongo is 'no cost to you' via sponsors; direct-to-consumer chronic-condition apps face long sales cycles, and a meta-discernment layer adds no clear single-willingness-to-pay buyer without EHR or payer integration.Virta Self-Pay Costs: FAQ'sOmada Health: Pricing, Free Demo & Features (2026) | Software FinderOnline Chronic Care Management | Livongo by Teladoc Health

Longevity
8/10

Tailwinds are durable: chronic disease prevalence (diabetes, obesity, hypertension) rising globally; wearables and AI-generated lifestyle advice both expanding, which amplifies the 'too much conflicting input' pain the product addresses.Disease Management Apps Market Size & Share Report, 2025-2033

Feasibility
5/10

Buildable but non-trivial: requires ingesting personal 'numbers' (labs, CGM, BP, weight), connecting to wearables + social/AI content streams, and producing per-user impact estimates; modeling personal causal impact of arbitrary lifestyle changes is harder than rule-based tracking, and HIPAA/health-data plumbing is heavy.Best Apps and Digital Tools for Blood Sugar Symptom Tracking: 2024 Review Guide

A Calculus of Discernment: Decision-Relevant Insight, Sequence Value, and Forgetting as Higher-Order LearningarXiv cs.AI · 2026-07-22 (3d ago)